Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep1220 | Clinical Cases–Pituitary/Adrenal | ECE2015

Occurrence of liver failure in post-surgery hypopituitaric patients

Lo Preiato Valentina , Ribichini Danilo , Baccini Margherita , Pasquali Renato , Pagotto Uberto

Multiple pituitary hormone deficit and hypothalamic obesity are common complications after brain surgery for childhood tumors. Despite adequate replacement hormone therapy, obesity develops equally, but liver failure is not usually described. In this study, four subjects who had undergone surgery for brain tumors involving the peri-hypothalamic area when they were nursing or as youths (9 months, 6 years, 9 years and 20 years). They were referred to our Unit when they were 19, ...

ea0081p323 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Sleep quality in patients with type 1 diabetes: a large cross-sectional study

Bongiorno Claudio , Moscatiello Simona , Laffi Gilberto , Ribichini Danilo , Lo Preiato Valentina , Grimaldi Michele , Pagotto Uberto , Di Dalmazi Guido

Background: Altered sleep quality and duration have been reported in 26-67% of patients with type 1 diabetes (T1D). However, differences in study designs, populations, and methods of sleep quality assessment have led to heterogeneous results in terms of association with clinical data and blood glucose parameters.Aims: To investigate the sleep quality of a large cohort of adult patients with autoimmune diabetes under insulin treatment, and to analyze the ...

ea0070aep535 | Endocrine-related Cancer | ECE2020

Endocrine related immune adverse events associated with programmed death ligand-1 (PD-L1) therapy in hematologic malignancies: A retrospective analysis

Lo Preiato Valentina , Buganè Anna , Casadei Beatrice , Argnani Lisa , Luigi Zinzani Pier , Pagotto Uberto , Pelusi Carla

Background: PD-L1 represents a novel class of drugs for treatment of a broad spectrum of malignancies including onco-hematologic diseases. This treatment is associated with several immuno-related adverse events (irAEs). Thyroid diseases and diabetes are among the most common PD-L1 endocrine-irAEs reported in solid cancers.Aims: To describe the frequency, the onset and the characteristics of PD-L1 endocrine-irAEs in patients with hematologic malignancies....

ea0070aep999 | Thyroid | ECE2020

Pembrolizumab inducing thyroid diseases: Are there differences between patients treated for lung carcinomas and those for lymphomas?

Lo Preiato Valentina , Buganè Anna , Casadei Beatrice , Salvagni Stefania , Argnani Lisa , Ardizzoni Andrea , Luigi Zinzani Pier , Pagotto Uberto

Background: In the last years, Pembrolizumab has been used to treat solid and lymphatic neoplasms, showing improved patients’ survival. Due to its mechanism of action, Pembrolizumab may be responsible of several immune-related adverse events (irAEs). The most frequent endocrine-irAEs reported are thyroid diseases.Aims: The aim of this study was to evaluate differences in thyroid disease incidence and presentation between patients treated for lung c...

ea0090p346 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Sex-driven factors associated with anxiety and depression in Type 1 Diabetes Mellitus (T1DM) and Latent Autoimmune Diabetes in Adults (LADA)

Saudelli Enrico , Moscatiello Simona , Baldari Michele , Bongiorno Claudio , Zucchini Stefano , Maltoni Giulio , Agostini Alessandro , Ribichini Danilo , Bruco Alessia , Lo Preiato Valentina , Laffi Gilberto , Pagotto Uberto , Di Dalmazi Guido

Aim: To analyze the prevalence of anxiety and depression in a large cohort of adults affected by autoimmune diabetes and to identify the associated factors, stratifying them according to sex.Methods: We administered to 553 patients with autoimmune diabetes the questionnaires: Hospital Anxiety and Depression Scale (HADS), Diabetes Distress Scale, Diabetes-related Quality of Life and Diabetes Treatment Satisfaction Questionnaire. We excluded 119 patients w...